EUVIMEDEUVIMED entdecken
Open Access

Clinical Implications of Missed CKD Diagnosis in Adults with and without Diabetes Mellitus

Nomy Levin-Iaina iD, Anat Reiner-Benaim iD, Shaden Abu-Akel iD, Nayaf Habashi

Journal of the American Society of Nephrology · 2026

DOI: 10.1681/asn.0000001005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026. Verfasst von Nomy Levin-Iaina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Missed Diagnosis, Diabetes Mellitus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points CKD was undiagnosed in 56% of patients and linked to early mortality, kidney failure, and cardiovascular events despite milder disease. First-year mortality was two-fold higher among undiagnosed patients, emphasizing the short-term risks of missed diagnosis. Sodium-glucose cotransporter 2 inhibitors were associated with better cardiovascular and kidney outcomes, yet their uptake remained low.

Background

CKD is a global public health challenge, yet underdiagnosis in routine care remains pervasive, leading to missed opportunities for early intervention. Evidence directly linking missed diagnosis to adverse outcomes in large, nationwide populations is limited.

Methods

We conducted a nationwide, population-based cohort study including 640,217 adults meeting Kidney Disease Improving Global Outcomes (KDIGO) laboratory criteria for CKD (eGFR30 mg/g on at least two occasions ≥3 months apart) between 2000 and 2023. CKD underdiagnosis was defined as absence of a documented diagnosis in electronic medical records. The primary end point was a composite of all-cause mortality or KRT. Secondary end points included first-year mortality and time to all-cause mortality, KRT, and major cardiovascular events. Associations were assessed using multivariable Cox proportional hazards models, stratified by diabetes status, with additional propensity score–matched sensitivity analyses.

Results

Of 640,217 patients who met laboratory criteria for CKD, 359,805 (56%) lacked a documented diagnosis. Undiagnosed patients were younger, more often female, and disproportionately from minoritized populations. Absence of a CKD diagnosis was associated with a markedly shorter time to death or KRT (hazard ratio, 1.10; 95% confidence intervals [CI], 1.09 to 1.11). First-year mortality was higher in undiagnosed versus diagnosed CKD (8.0% [95% CI, 7.9 to 8.1] versus 4.1% [95% CI, 4.0 to 4.2]), despite less advanced disease at baseline. Use of renoprotective and cardioprotective medications was significantly lower in undiagnosed patients. Sodium-glucose cotransporter 2 (SGLT2) inhibitor therapy was independently associated with lower risks of death, kidney failure, and cardiovascular events, showing a consistent protective effect in both diabetic and nondiabetic subgroups. Findings were consistent across sensitivity analyses.

Conclusions

In this real-world nationwide CKD cohort, underdiagnosis was common and associated with premature death, kidney failure, and cardiovascular morbidity. There was consistent association of SGLT2 inhibitors with better cardiovascular and kidney health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicMissed DiagnosisDiabetes MellitusHumansFemaleMiddle AgedMaleAgedCohort StudiesCardiovascular DiseasesSodium-Glucose Transporter 2 Inhibitors

Stichwörter der Autor:innen

CKDcardiovascular eventsclinical nephrologycommunity engagement and healthdiabetes mellitusepidemiology and outcomes

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Nephrology and Hypertension, Barzilai University Medical Center, Ashkelon, Israel.
  • Faculty of Health Sciences, School of Medicine, Ben Gurion University of the Negev, Beer Sheva, Israel.
  • Department of Epidemiology, Biostatistics and Community Health Sciences, Faculty of Health Sciences, School of Public Health, Ben Gurion University of The Negev, Beer Sheva, Israel.
  • Department of Nephrology, HaEmeq Hospital Afula, Afula, Israel.
  • Clalit Health Services, Israel.
  • Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

ORCID-Profile: Nomy Levin-Iaina, Anat Reiner-Benaim, Shaden Abu-Akel

Zitieren

APA

Levin-Iaina, N., Reiner-Benaim, A., Abu-Akel, S., & Habashi, N. (2026). Clinical Implications of Missed CKD Diagnosis in Adults with and without Diabetes Mellitus. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001005

Vancouver

Levin-Iaina N, Reiner-Benaim A, Abu-Akel S, Habashi N. Clinical Implications of Missed CKD Diagnosis in Adults with and without Diabetes Mellitus. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001005

BibTeX
@article{LevinIaina2026,
  author = {Levin-Iaina, Nomy and Reiner-Benaim, Anat and Abu-Akel, Shaden and Habashi, Nayaf},
  title = {Clinical Implications of Missed CKD Diagnosis in Adults with and without Diabetes Mellitus},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.1681/asn.0000001005}
}
Kostenlos starten →